Antitumor anthracylcine antibiotics

Details Antitumor anthracylcine antibiotics Antitumor anthracylcine antibiotics

C - Chemistry, Metallurgy

12

P

195/105

C12P 19/56 (2006.01) C07H 15/252 (2006.01)

Patent

CA 1100895

ABSTRACT OF THE DISCLOSURE New antitumor agents designated MA144-G1, -G2, -L, -N1, -S1, -S2, -U1, -U2 and -Y, which are anthracycline glycosides and inhibit the growth of gram-positive bacteria, e.g. Corynebacterium bovis, Staphvlococcus aureus, Nicrococcus, flavus and inhibit the growth of animal tumors such as leukemia L1210 in mice are produced by fermentation of a microorganism belonging to the genus Streptomyces.

287886

Affiliated with

Also associated with

Rating

Antitumor anthracylcine antibiotics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor anthracylcine antibiotics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor anthracylcine antibiotics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-405668